STOCK TITAN

Establishment Labs (ESTA) director-linked entity sells 3,575 common shares

Filing Impact
(Moderate)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Establishment Labs Holdings Inc. director Juan Jose Chacón Quirós reported an indirect open-market sale of 3,575 common shares at a weighted average price of $60.075 per share. The shares were sold by Sariel Group Ltd. under a pre-arranged Rule 10b5-1 trading plan.

After the sale, indirect holdings reported for Sariel Group Ltd. totaled 1,220,004 common shares, and Chacón Quirós also reported 45,193 common shares held directly. He disclaims beneficial ownership of shares held by Sariel Group Ltd. except to the extent of his pecuniary interest.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Chacon Quiros Juan Jose

(Last)(First)(Middle)
C/O MOTIVA USA LLC
16192 COASTAL HIGHWAY

(Street)
LEWES DELAWARE 19958

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
ESTABLISHMENT LABS HOLDINGS INC. [ ESTA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
03/25/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Shares03/25/2026S(1)3,575D$60.075(2)1,220,004ISee Footnote(3)
Common Shares45,193D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
2. This transaction was executed in multiple trades at prices ranging from $60.00 to $60.32 per share. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
3. The shares are held by Sariel Group Ltd. The Reporting Person is a shareholder of Sariel Group Ltd and has voting and dispositive power over the shares owned by Sariel Group Ltd. The Reporting Person disclaims beneficial ownership of the shares held by Sariel Group Ltd, except to the extent of his pecuniary interest therein.
Remarks:
/s/ Juan Jose Chacon Quiros03/27/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did ESTA director Juan Jose Chacón Quirós report?

Juan Jose Chacón Quirós reported an indirect open-market sale of 3,575 Establishment Labs common shares. The sale was executed at a weighted average price of $60.075 per share by Sariel Group Ltd., an entity in which he holds an interest and voting and dispositive power.

Who actually sold the Establishment Labs (ESTA) shares in this Form 4?

The shares were sold by Sariel Group Ltd., which holds Establishment Labs common shares. Juan Jose Chacón Quirós is a shareholder of Sariel Group Ltd. with voting and dispositive power but disclaims beneficial ownership beyond his pecuniary interest in the entity’s holdings.

How many ESTA shares were sold and at what price in the latest insider trade?

The filing shows an indirect sale of 3,575 Establishment Labs common shares at a weighted average price of $60.075 per share. The transaction occurred through multiple trades between $60.00 and $60.32 per share, aggregated into the reported average price.

What are Juan Jose Chacón Quirós’s reported holdings in ESTA after this transaction?

After the sale, indirect holdings via Sariel Group Ltd. are reported at 1,220,004 Establishment Labs common shares, and direct holdings are 45,193 common shares. These figures come from the post-transaction balances disclosed in the Form 4 for both indirect and direct ownership.

Was the ESTA insider sale made under a Rule 10b5-1 trading plan?

Yes. The footnotes state the sale was effected under a Rule 10b5-1 trading plan adopted by the reporting person. Such plans pre-schedule trades, meaning the timing of this Establishment Labs share sale was set in advance rather than decided opportunistically.

Does the ESTA director fully own the shares held by Sariel Group Ltd.?

The filing explains that the shares are held by Sariel Group Ltd., where Juan Jose Chacón Quirós has voting and dispositive power. He formally disclaims beneficial ownership of those shares, except for the portion corresponding to his actual pecuniary interest in the entity.
Establishment Labs Hldgs Inc

NASDAQ:ESTA

View ESTA Stock Overview

ESTA Rankings

ESTA Latest News

ESTA Latest SEC Filings

ESTA Stock Data

1.76B
26.38M
Medical Devices
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
United States
ALAJUELA